Loading people...
James Blair is a founding Partner at Domain Associates, a life sciences venture capital firm based in the Greater San Diego Area, where he oversees healthcare investments and manages the firm's legacy portfolio. Prior to establishing Domain Associates in 1985, he served as a Managing Director at Rothschild and worked as an engineering manager at RCA Corporation. Over a four-decade career, he has directed early-stage funding and served on the board of directors for more than forty biotechnology and medical device companies, including Amgen, NuVasive, and Zogenix. He has consistently guided these emerging startups through critical clinical development phases, initial public offerings, and strategic acquisitions, such as the recent $1.9 billion acquisition of Zogenix by UCB. Blair holds a BSE from Princeton University, alongside an MSE and a PhD in electrical engineering from the University of Pennsylvania.
James Blair stands as a pivotal Partner at Domain Associates, a globally recognized venture capital firm renowned for its deep expertise and significant impact within the life sciences industry. As a key member of the investment team, Mr. Blair is instrumental in shaping the future of healthcare by identifying, funding, and guiding innovative companies from their nascent stages through to market leadership.
At Domain Associates, James Blair's investment focus is sharply honed on the most promising areas within life sciences. His portfolio typically spans biotechnology, pharmaceuticals, medical devices, diagnostics, and increasingly, digital health solutions that aim to revolutionize patient care and outcomes. He possesses a keen eye for disruptive technologies and therapeutic platforms that address significant unmet medical needs. Mr. Blair is particularly adept at evaluating complex scientific data and market dynamics, enabling him to back companies with strong intellectual property, robust clinical pipelines, and scalable business models. His strategic insights help portfolio companies navigate regulatory landscapes, accelerate product development, and achieve commercial success.
James Blair's extensive career background provides a solid foundation for his success in venture capital. Prior to joining Domain Associates, he cultivated a rich professional history that often includes significant roles in scientific research, corporate development within pharmaceutical or biotech companies, or previous experience in healthcare investment banking. This diverse experience equips him with a comprehensive understanding of the entire drug and device development lifecycle, from discovery to commercialization. His academic credentials, often including advanced degrees in life sciences or business, further bolster his analytical capabilities and strategic foresight. At Domain Associates, Mr. Blair is not just a capital provider; he is a hands-on partner, leveraging his network and operational expertise to support management teams, recruit talent, and forge strategic partnerships for portfolio companies.
While specific investment details are often confidential, James Blair has been associated with numerous successful ventures that have brought significant advancements to medicine. His involvement has helped launch and grow companies that have developed novel therapies for challenging diseases, introduced next-generation medical devices, or created innovative diagnostic tools that improve patient stratification and treatment. These investments underscore his commitment to fostering companies that not only generate strong financial returns but also deliver substantial societal benefit. Through his work at Domain Associates, James Blair continues to play a critical role in advancing healthcare innovation, making a lasting impact on patients' lives worldwide.
James Blair is a distinguished Partner at Domain Associates, a leading venture capital firm specializing in the life sciences sector. He is known for his expertise in identifying and investing in innovative biotechnology, pharmaceutical, and medical device companies.
James Blair primarily invests in life sciences companies, with a focus on biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions. He seeks out disruptive technologies and therapeutic platforms addressing unmet medical needs.
James Blair works as a Partner at Domain Associates, a prominent venture capital firm dedicated to investing in and nurturing companies within the life sciences industry.
